Cambridge, MA, United States of America

David E Wald

This inventor holds 1 USPTO granted patent. Top assignee: Dragon Systems, Inc.. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 69(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of David E Wald

Introduction

David E Wald is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of speech recognition technology. His innovative approach has led to the development of a unique patent that enhances user enrollment in speech recognition systems.

Latest Patents

David E Wald holds a patent related to the enrollment in speech recognition. This patent involves a method for enrolling a user in a speech recognition system by analyzing the acoustic content of a user utterance. The process determines whether the utterance matches a portion of an enrollment text. If a match is found, the acoustic content is utilized to update the acoustic models corresponding to that portion of the enrollment text. This innovation is crucial for improving the accuracy and efficiency of speech recognition systems. He has 1 patent to his name.

Career Highlights

David E Wald is currently employed at Dragon Systems, Inc., where he continues to work on advancing speech recognition technologies. His expertise and dedication to innovation have made him a valuable asset to the company.

Collaborations

Some of his notable coworkers include Francesco Scattone and Toffee A Albina. Their collaborative efforts contribute to the ongoing development of cutting-edge technologies in the field.

Conclusion

David E Wald's contributions to speech recognition technology exemplify the impact of innovative thinking in the tech industry. His work continues to influence advancements in user interaction with speech recognition systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…